University of Texas MD Anderson Cancer Center

Hospital


Location: Houston, United States (USA) (US) US

ISNI: 0000000122914776

ROR: https://ror.org/04twxam07

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Translating ctDNA into cutaneous melanoma care: An international expert survey (2026) Geidel G, Fekade N, Raabe K, Smit DJ, Adam L, Heidrich I, Rünger A, et al. Journal article Immune checkpoint inhibitor-associated myocarditis: A novel risk score (2026) Power JR, Dolladille C, Ozbay B, Procureur A, Ederhy S, Palaskas NL, Lehmann LH, et al. Journal article Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma (2026) Weeda YA, Salgado R, van Herpe F, Sur D, Vieth M, Loi S, Tafti AP, et al. Journal article, Review article Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis (2026) Oertel M, Dabaja B, Görlich D, Thomas BR, Sim V, Johnstone P, Hashmi A, et al. Journal article Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025) Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching P, Bardia A, Chia S, et al. Journal article The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer: A Review † (2025) Dok R, Nuyts S, Lopez F, Bradford C, Forastiere AA, Strojan P, Agaimy A, et al. Journal article, Review article Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial (2025) Fasching P, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, et al. Journal article Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report (2025) Van den Bent MJ, Vogelbaum MA, Cloughesy T, Galldiks N, Albert NL, Tonn JC, Avila E, et al. Journal article, Review article Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer (2025) Al-Hilal TA, Chrysovergi MA, Grasberger PE, Liu F, Auernheimer V, Zhou Y, Xiao Z, et al. Journal article Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis (2025) Fu Z, Borho L, Taylor SE, Kelemen LE, DeFazio A, Webb PM, Köbel M, et al. Journal article